Open AccessState of the Science and Future Directions for Liquid Biopsies in Drug Development
Author(s) -
Narayan Preeti,
Ghosh Soma,
Philip Reena,
Barrett J. Carl,
McCormack Robert T.,
Odegaard Justin I.,
R. Oxnard Geoffrey,
Pracht Laurel J.,
Williams P. Mickey,
Kelloff Gary J.,
Beaver Julia A.
Publication year - 2020
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2020-0246
Subject(s) - medicine , liquid biopsy , medical physics , drug development , precision oncology , anticancer drug , intensive care medicine , drug , precision medicine , cancer , pathology , pharmacology
With advances in precision oncology, liquid biopsies have shown promise as a minimally invasive means to diagnose cancer and guide treatment decisions. This commentary presents an assessment of the potential and the challenges of widespread use of liquid biopsy testing, based on the 2019 Accelerating Anticancer Agent Development Workshop.